Proteomics International Laboratories (ASX:PIQ) FCF Margin % : -277.51% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Proteomics International Laboratories FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Proteomics International Laboratories's Free Cash Flow for the six months ended in Dec. 2023 was A$-1.72 Mil. Proteomics International Laboratories's Revenue for the six months ended in Dec. 2023 was A$0.62 Mil. Therefore, Proteomics International Laboratories's FCF Margin % for the quarter that ended in Dec. 2023 was -277.51%.

As of today, Proteomics International Laboratories's current FCF Yield % is -4.13%.

The historical rank and industry rank for Proteomics International Laboratories's FCF Margin % or its related term are showing as below:

ASX:PIQ' s FCF Margin % Range Over the Past 10 Years
Min: -985.03 Med: -174.92 Max: -96.43
Current: -985.03

During the past 9 years, the highest FCF Margin % of Proteomics International Laboratories was -96.43%. The lowest was -985.03%. And the median was -174.92%.

ASX:PIQ's FCF Margin % is ranked worse than
75.22% of 1041 companies
in the Biotechnology industry
Industry Median: -145.04 vs ASX:PIQ: -985.03

Proteomics International Laboratories FCF Margin % Historical Data

The historical data trend for Proteomics International Laboratories's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proteomics International Laboratories FCF Margin % Chart

Proteomics International Laboratories Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Margin %

Get a 7-Day Free Trial

-116.14

-138.51

-184.13

-246.41

-946.71

Proteomics International Laboratories Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial													-192.41	-287.78	-378.49	10,832.43	-277.51

Competitive Comparison of Proteomics International Laboratories's FCF Margin %

For the Biotechnology subindustry, Proteomics International Laboratories's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Proteomics International Laboratories's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Proteomics International Laboratories's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Proteomics International Laboratories's FCF Margin % falls into.

Proteomics International Laboratories FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Proteomics International Laboratories's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-6.911	/	0.73
	=	-946.71 %

Proteomics International Laboratories's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-1.715	/	0.618
	=	-277.51 %

Proteomics International Laboratories FCF Margin % Related Terms

Thank you for viewing the detailed overview of Proteomics International Laboratories's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Proteomics International Laboratories (ASX:PIQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Proteomics International Laboratories Ltd (ASX:PIQ) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Verdun Street, QEII Medical Centre, QQ Block, Nedlands, Perth, WA, AUS, 6009

Website

https://www.proteomics.com.au

Proteomics International Laboratories Ltd is a biological research and drug discovery company. The company specializes in the area of proteomics which is the industrial-scale study of the structure and function of proteins. Its operations are divided into PromarkerD which targets the diabetes epidemic and is a predictive diagnostic test for diabetic kidney disease, a progressive disorder found in one in three adults with diabetes; its proprietary biomarker discovery platform called Promarker, which searches for protein fingerprints in a sample; and Analytical Services that are specialist contract research focusing on biosimilars quality control and pharmacokinetic testing for clinical trials.

Proteomics International Laboratories (ASX:PIQ) Headlines

No Headlines